These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18448872)

  • 1. VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study.
    Kinkingnéhun S; Sarazin M; Lehéricy S; Guichart-Gomez E; Hergueta T; Dubois B
    Neurology; 2008 Jun; 70(23):2201-11. PubMed ID: 18448872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.
    Chételat G; Landeau B; Eustache F; Mézenge F; Viader F; de la Sayette V; Desgranges B; Baron JC
    Neuroimage; 2005 Oct; 27(4):934-46. PubMed ID: 15979341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment.
    Hämäläinen A; Tervo S; Grau-Olivares M; Niskanen E; Pennanen C; Huuskonen J; Kivipelto M; Hänninen T; Tapiola M; Vanhanen M; Hallikainen M; Helkala EL; Nissinen A; Vanninen R; Soininen H
    Neuroimage; 2007 Oct; 37(4):1122-31. PubMed ID: 17683950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease.
    Testa C; Laakso MP; Sabattoli F; Rossi R; Beltramello A; Soininen H; Frisoni GB
    J Magn Reson Imaging; 2004 Mar; 19(3):274-82. PubMed ID: 14994294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease.
    Soto ME; Andrieu S; Cantet C; Reynish E; Ousset PJ; Arbus C; Gillette-Guyonnet S; Nourhashémi F; Vellas B;
    Dement Geriatr Cogn Disord; 2008; 26(2):109-16. PubMed ID: 18617740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voxel-based morphometry to discriminate early Alzheimer's disease from controls.
    Hirata Y; Matsuda H; Nemoto K; Ohnishi T; Hirao K; Yamashita F; Asada T; Iwabuchi S; Samejima H
    Neurosci Lett; 2005 Jul; 382(3):269-74. PubMed ID: 15925102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of progression differs in frontotemporal dementia and Alzheimer disease.
    Rascovsky K; Salmon DP; Lipton AM; Leverenz JB; DeCarli C; Jagust WJ; Clark CM; Mendez MF; Tang-Wai DF; Graff-Radford NR; Galasko D
    Neurology; 2005 Aug; 65(3):397-403. PubMed ID: 16087904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease.
    Baron JC; Chételat G; Desgranges B; Perchey G; Landeau B; de la Sayette V; Eustache F
    Neuroimage; 2001 Aug; 14(2):298-309. PubMed ID: 11467904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The topography of grey matter involvement in early and late onset Alzheimer's disease.
    Frisoni GB; Pievani M; Testa C; Sabattoli F; Bresciani L; Bonetti M; Beltramello A; Hayashi KM; Toga AW; Thompson PM
    Brain; 2007 Mar; 130(Pt 3):720-30. PubMed ID: 17293358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated method for identification of patients with Alzheimer's disease based on three-dimensional MR images.
    Arimura H; Yoshiura T; Kumazawa S; Tanaka K; Koga H; Mihara F; Honda H; Sakai S; Toyofuku F; Higashida Y
    Acad Radiol; 2008 Mar; 15(3):274-84. PubMed ID: 18280925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease.
    Apostolova LG; Lu PH; Rogers S; Dutton RA; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Alzheimer Dis Assoc Disord; 2006; 20(4):224-31. PubMed ID: 17132966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Voxel-based morphometric study of brain structure in Alzheimer's disease].
    Yuan Q; Zou L; Chen Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):496-9. PubMed ID: 18575352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
    Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
    Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
    Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
    Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry.
    Chaim TM; Duran FL; Uchida RR; Périco CA; de Castro CC; Busatto GF
    Psychiatry Res; 2007 Jan; 154(1):59-68. PubMed ID: 17174533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.